RxDoctor Payments Data

Thomas Whisenhunt, PhD

Neurological Surgery · Auburn, ALNPI 1275736365

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Life Spine, Inc. at 42.0% of the total. 2025 is the largest year on record at $3,947, 4.8 times the $820 reported in 2019.

$10,068in general payments, 2019–2025

Across 142 payments — averaging $70.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Life Spine, Inc.$4K
  • Medacta USA, Inc.$2K
  • Abbott$1K
  • Providence Medical Technology, Inc.$620
  • Stryker$589
  • Medtronic$391
  • plus $1K from 22 others

What the payments were for

  • Travel & lodging$2,27423%
  • Food & beverage$5,07050%
  • Education$2,72527%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,068 in reported general payments places this provider in the 80th percentile of 97 neurological surgery providers in Alabama.

See all neurological surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$116,924
Medicare patients
213
Services billed
429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl134$1,440
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen112$1,093

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Auburn

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →